Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasia.
Junyu ChenDongyan CaoJiaxin YangMei YuHuimei ZhouNinghai ChengJinhui WangYing ZhangPeng PengKeng ShenPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
GnRHa combined treatment provides favorable oncological and reproductive outcomes. Larger multi-institutional studies are required to confirm these preliminary findings.